0001144204-12-025640.txt : 20120502 0001144204-12-025640.hdr.sgml : 20120502 20120502163805 ACCESSION NUMBER: 0001144204-12-025640 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120430 FILED AS OF DATE: 20120502 DATE AS OF CHANGE: 20120502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHUMACHER RICHARD T CENTRAL INDEX KEY: 0001033775 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21615 FILM NUMBER: 12805774 MAIL ADDRESS: STREET 1: 375 WEST STREET CITY: WEST BRIDGEWATER STATE: MA ZIP: 02379 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PRESSURE BIOSCIENCES INC CENTRAL INDEX KEY: 0000830656 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] IRS NUMBER: 042652826 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14 NORFOLK AVENUE CITY: SOUTH EASTON STATE: MA ZIP: 02375 BUSINESS PHONE: 5082301828 MAIL ADDRESS: STREET 1: 14 NORFOLK AVENUE CITY: SOUTH EASTON STATE: MA ZIP: 02375 FORMER COMPANY: FORMER CONFORMED NAME: BOSTON BIOMEDICA INC DATE OF NAME CHANGE: 19960812 4 1 form450247_20120502043628-.xml X0305 4 2012-04-30 0 0000830656 PRESSURE BIOSCIENCES INC PBIO 0001033775 SCHUMACHER RICHARD T 130 LAKE RIDGE DRIVE TAUNTON MA US 02780 1 1 0 0 CEO Common Stock 2012-04-30 4 C 0 93786 0.8025 A 462152 D Common Stock 2012-04-30 4 J 0 4652 0.8025 A 466804 D Series C Convertible Preferred Stock 0.8025 2012-04-30 4 C 0 5018 D 2011-04-08 Common Stock 93786 0 D Common Stock Purchase Warrant 2.38 2012-04-30 4 C 0 50180 D 2011-04-08 2014-04-08 Common Stock 50180 0 D Common Stock Purchase Warrant 0.74 2012-04-30 4 C 0 46894 A 2012-04-05 2017-04-05 Common Stock 46894 46894 D The Series C Convertible Preferred Stock has no expiration date. Pursuant to a certain Securities Purchase Agreement, dated April 8, 2011, among the Company, the Reporting Person and the other purchasers named therein, the Reporting Person purchased 5,018 "Units" at a purchase price of $15.00 per Unit. Each Unit consisted of (i) one share of Series C Convertible Preferred Stock convertible into 10 shares of common stock and (ii) a warrant to purchase one share of Common Stock, which warrant is exercisable until April 8, 2014. The Reporting Person exchanged these securities for 93,786 shares of the company's common stock with a value of $0.8025 per share and warrants to purchase 46,894 shares of the company's common stock at an exercise price of $0.74 per share. The shares acquired are the result of a 5% stock dividend on Pressure BioSciences, Inc. Series C Convertible Preferred Stock. Richard T Schumacher 2012-05-02